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ABSTRACT 
 
Objective: Random roadside oral fluid testing is becoming increasingly popular as an apprehension 
and deterrence-based countermeasure to reduce drug driving. This paper outlines research 
conducted to provide an estimate of the extent of drug driving in a sample of drivers in Brisbane, 
Queensland.  
Methods: Oral fluid samples were collected from 1587 drivers who volunteered to participate at 
Random Breath Testing (RBT) sites. Illicit substances tested for included cannabis (delta 9 
tetrahydrocannibinol [THC]), meth/amphetamines and cocaine. Drivers also completed a self-report 
questionnaire regarding their drug-related driving behaviour.  
Results: Oral fluid samples from 58 participants (3.7%) were confirmed positive for at least one illicit 
substance. The most common drugs detected in oral fluid were ecstasy (n = 35) followed by cannabis 
(n = 20). Similarly, cannabis was confirmed as the most common self-reported drug combined with 
driving. Nevertheless, individuals who tested positive to any drug through oral fluid analysis were also 
more likely to report the highest frequency of drug driving.  
Conclusions: This research provides evidence that drug driving is relatively prevalent on some 
Queensland roads, and thus the behaviour presents as a serious road safety threat. This paper will 
further outline the study findings and present possible directions for future drug driving research.   
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INTRODUCTION 
In recent years, an increasing body of literature has focused on ascertaining the incidences and effect 
of drug driving on road safety. A significant amount of research is accruing that has focused on 
identifying the presence of drugs in body fluids of those who have been involved in a crash. This 
research has demonstrated that between 8.8 and 26.7 percent of drivers fatally injured in crashes 
have drugs detected in their body fluid and between 2.7 to 41.3 percent of non-fatally injured drivers 
in traffic crashes also test positive to illicit substances (Del Rio et al., 2002; Drummer et al., 2003; 
Mura et al., 2006; Seymour & Oliver, 1999; Swann et al., 2004). Furthermore within Australia, a study 
of fatalities on the roads indicated 26.7 per cent of motorists killed had drugs other than alcohol 
detected in body fluids (Drummer et al., 2003). However, the percentage of the general driving 
population (not involved in crashes) that are driving after consuming drugs remains unclear due to 
difficulties testing for drugs and detecting motorists driving under the influence.   
 
The main avenue for obtaining such information has traditionally been through self-report data 
provided by motorists. A considerable body of research has indicated that the self-reported 
prevalence of drug driving varies markedly between 2 and 90 percent of respondents, although most 
research suggests between 3 and 10 percent (Kelly et al., 2004). This variation is dependent upon 
whether respondents have been referring to drug driving in general or to a specific substance.  
Despite this, research is generally indicating that the most common drugs combined with driving are 
usually cannabis (Davey et al., 2007; Drummer et al., 2003; Terry & Wright, 2005), which may in part 
be associated with perceptions that cannabis does not have a negative impact on driving 
performance (Terry & Wright, 2005). Although, amphetamine use and driving are also frequently 
combined among some groups (Albery et al., 2000; Davey et al., 2007; Darke et al., 2004).  
Additionally, it is noted that a limitation of this body of research is that such studies have 
predominantly consisted of cannabis users.   
 
Nevertheless, drug driving appears prevalent in Australia, as a growing body of research has 
indicated some motorists drive after consuming illicit drugs (Armstrong et al., 2005; Darke et al., 
2004; Davey et al., 2007; Hawkins et al., 2004; Jones et al., 2005; Mallick et al., 2007). A large 
contemporary Australian study of 6801 drivers revealed that 12.3 percent of the sample reported 
driving within 3 hours of using cannabis in the past 12 months and a considerable proportion of the 
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sample reported poly drug use (Mallick et al., 2007). And similar to above, illicit drug users were more 
likely to perceive there to be less risks associated with drug driving than non-users (Mallick et al., 
2007).  Additionally, smaller Australian studies that have focused on young drivers (e.g., university 
students) have also revealed similar results, as between 8.2 and 15 percent of motorists reported 
driving after consuming some form of illicit substance on a yearly basis (Armstrong et al., 2005; 
Davey et al., 2005a).   
 
However, the development and use of oral fluid in drug testing for roadside use has greatly increased 
the likelihood of more accurately determining the prevalence of drug driving, as sample collection is 
relatively simple and non-invasive (Dolan et al., 2004; Speedy et al., 2004).  Previous research 
concerning body fluid sample analysis has focused on samples of drivers alleged to have been 
driving under the influence of drugs and/or those involved in vehicle crashes. However, more 
recently, research has commenced focusing on random roadside drug testing which is beginning to 
provide an estimate of the extent of drug driving on public roads, including those who are not involved 
in crashes. One recent study in this area reported 4.7 percent of drivers from a random sample of 
non-crash drivers in Britain, were confirmed positive to the presence of drugs (Buttress et al., 2004). 
Additionally, a study conducted in Germany found a significant proportion (16.8%) of drivers were 
confirmed positive for at least one drug (Wylie et al., 2005).  
 
One of the few Australian studies in this area was conducted by the Victorian police who recorded a 
drug driving prevalence rate of one driver in 40 (2.4%) for cannabis and amphetamines, which is 
more than double the positive alcohol-driving rate (Drummer et al., 2007). Davey et al. (2007) also 
examined the extent of drug driving in Townsville (Queensland) and reported 3.5 percent of the 
sample tested positive to one illicit substance, which was again in fact greater than the detection of 
drink drivers during the same testing period (e.g., 0.8%). Interestingly, a three-year study of police 
traffic detainees in three Australian states found that 70 percent tested positive to one drug and 
approximately one third (e.g., 38%) tested positive to more than one drug (Poyser et al., 2002). A 
similar Australian study that examined motorists involved in traffic accidents revealed that 16.4 
percent of injured drivers tested positive to tetrahydrocannabinol and 6.9 percent tested positive to 
amphetamines (Caldicott et al., 2007). These preliminary findings indicate that drug driving presents 
as a serious threat to road safety, and additionally prompts the need for further research to determine 
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the extent of non-crash drug driving rates in Australia, especially for drugs such as cannabis, 
amphetamine, ecstasy, and cocaine.   
 
 As a result, the major objectives of this study were to: 
• Measure the extent of drug driving among a sample of Queensland drivers in the city of 
Brisbane; and 
• Investigate the self-reported frequency of general motorists’ involvement in drug driving 
behaviour 
 
METHOD  
Participants, Materials and Procedure 
Drivers stopped at Random Breath Testing (RBT) operations across the city of Brisbane were 
approached and asked by operational police to participate in the drug driving research project, which 
was positioned on average 50 metres further down the road. Participation was voluntary and involved 
completing a self-report questionnaire regarding recent illicit drug use and drug driving in the previous 
12 months, and providing a sample of oral fluid that could later be screened for the presence of 
drugs. The procedure took approximately 10-20 minutes to complete and drivers received a one-off 
payment of $20 cash to reimburse them for their time. Data was collected over a two month period, 
on ten separate occasions, usually between the hours of 5pm and 1am1.   
 
A 12 item self-report questionnaire was designed to assess a variety of demographic data (e.g., 
gender, age, years driving) as well as self-reported drug use and the frequency of drug driving 
behaviour.  Participants responded to questions that investigated the most recent use of marijuana / 
cannabis (within four hours, within the last 24 hours, within the last week, within the last month, within 
the last year, more than a year ago, have never used). This question was repeated for amphetamines 
(such as speed, oil, base, crystal, ecstasy), heroin and cocaine. Participants were also required to 
indicate how often in the previous 12 months they had operated a motor vehicle (including a 
motorcycle) within four hours of using marijuana / cannabis (every day, more than once a week, 
about once a week, 11 – 20 times, 3 – 10 times, once or twice, never). Once again, this question was 
                                                 
1 Workplace health and safety requirements resulted in the current roadside project only being implemented with 
the presence of the Queensland Police Service. RBT operations were deemed to be the most compatible 
roadside activity and thus drug testing procedures corresponded within traditional RBT operational hours e.g., 
5pm – 1am.   
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repeated for amphetamines (such as speed, oil, base, crystal, ecstasy), heroin and cocaine. The 
majority of data was descriptive and/or categorical, and recorded as percentage frequencies, and 
thus, chi-square tests were performed where appropriate.   
 
In addition, oral fluid samples were collected, stored and screened off-site at a later date using the 
Cozart® RapiScan oral fluid drug test device. Participants provided a sample of oral fluid that was 
collected from inside their mouth via a pad held either under their tongue or beside the inside of their 
cheek.  The five-panel cannabis and single-panel methamphetamine / MDMA test cartridges were 
used (i.e. each sample was screened twice). Each Cozart® RapiScan kit consisted of a collector, 
transport tube containing buffer solution, separator filter tube, pipette and test cartridge. The five-
panel cannabis cartridge detected the presence of benzodiazepines, amphetamines, cannabis (THC), 
and cocaine, while the single-panel methamphetamine / MDMA cartridge detected the presence of 
methamphetamine and MDMA (ecstasy). There was no subjectivity in the interpretation of results as 
the Cozart® RapiScan testing instrument displayed and printed results. 
 
RESULTS 
Sample and Response Rate 
A total of 1587 motorists from the Brisbane area volunteered to participate in the study. Over the 
entire data collection stage, it was difficult to acquire an accurate measurement of the proportion of 
responses due to resourcing restrictions and the referral procedure from the Police RBT location2. 
However, on one occasion in the Brisbane region the response rate was assessed across two sites 
during a shift where an additional researcher counted the number of drivers approached to 
participate and noted their response. Drivers of 65 cars from a total of 91 participated in the project, 
resulting in a response rate of 71.42 percent. In addition, over the entire study, six potential 
participants approached the research site, but declined to participate after being informed about the 
research procedure.    
Overall, the sample consisted of both male and female participants with more than half being male (n 
= 1004, 63.3%), aged between 16 and 75 years (mean age = 30.06 years, SD = 12.02). On average, 
participants had been driving for 12.06 years (SD = 11.30) and the majority of the sample reported 
driving daily (n = 1353, 85.3%) or three to five times per week (n = 197, 12.4%).  
                                                 
2 The procedure usually consisted of RBT operational police officers informing motorists (who had given a breath 
sample) that they had the opportunity to participate in an anonymous research drug driving project being 
conducted approximately 50 metres down the road.   
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Extent of Positive Drug Screening Tests 
Drug screening tests revealed that oral fluid samples from 58 drivers (3.7% of the total sample) 
contained at least one illicit substance. Table 1 summarises the findings by drug group detected and 
gender of the driver. As depicted in Table 1, the most frequent drug detected was ecstasy, followed 
by cannabis, while samples from 15 participants were consistent with poly drug use.   
   
Juxtaposed with the total sample, the 58 drivers who provided samples that were screened positive 
for at least one illicit substance were more likely to be male (n = 47, 81%), and aged between 17 and 
53 (mean = 26.1 years, SD = 8.5), but had similar driving experience as the sample average (mean = 
8.68 years, SD = 8.68).  Rates of driving was similar, as most reported driving daily (n = 52, 89.7%) or 
three to five times per week (n = 4, 6.9%). In general, the prevalence of drug driving was higher 
among males than females, (n = 47, 81%) especially among poly drug users (n = 12, 80%).   
 
INSERT TABLE 1 HERE 
 
Self-reported Extent of Drug Driving 
In conjunction with the analysis of body fluids, an analysis was also undertaken to investigate 
participants’ self-reported drug use and drug driving behaviours. Firstly for drug use, the most 
commonly consumed drug was cannabis, with 21.3% reporting the use of the substance within the 
last year, and 3.2% of this group reporting usage in the last week.  In contrast, only 7.9% reported 
amphetamine use in the last year, with 0.7% using the substance in the last week. Ecstasy use 
however, was the 2nd most commonly consumed drug with 10.6% reporting the use of the substance 
within the last year, and 0.7% using the substance in the last week. Finally, 3.2% reported using 
cocaine and 0.4% of the sample reported using heroin during the last year. Chi-square analysis 
revealed males were more likely to report regular cannabis use than females X2 (6, N =1587, 
=19.723, p = .003), while small cell sizes precluded analysis of the other substances.  
 
For self-reported drug driving, the most common substance was cannabis (see Table 2). More 
specifically, 4.1% reported using cannabis before driving at least once a week, while less than 1.0% 
reported the use of amphetamines, ecstasy, cocaine or heroin before driving. Finally, examination of 
the self-reported drug use for the individuals who tested positive to the presence of drugs revealed 
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that drug driving was most common among these individuals. For example, 44 (75.9%) reported 
driving within four hours of using at least one of the drugs outlined on the questionnaire. This 
proportion is more than five times the proportion of the total sample of 1587 drivers that reported drug 
driving (221 drivers, 13.9%). Furthermore, 32 (55.2%) of the drivers who provided samples that were 
confirmed positive for at least one illicit substance reported drug driving frequently (that is, once a 
week or more). This is more than 9 times the proportion of the total sample that reported frequently 
drug driving (93 drivers, 5.9%).  
 
INSERT TABLE 2 HERE 
 
DISCUSSION 
The central aim of this paper was to report on an investigation into the incidences of drug driving in a 
major city of Queensland. More specifically, the study focused on measuring the self-reported extent 
of drug driving in the community and the major drug types that may be used when driving. 
 
Extent of Positive Drug Tests 
The first major finding of the study was that the examination of oral fluid samples revealed that 3.7% 
(n = 58) of the sample provided a positive illicit drug reading. The finding is consistent with the small 
amount of research that has focused on randomly drug testing motorists through oral fluid analysis 
(Buttress et al., 2004; Davey et al., 2007; Drummer et al., 2007). In addition, the detection rate for 
drug drivers (in the current case) appears higher than the recent detection rates for drink drivers in 
Queensland (Davey et al., 2007; Watson et al., 2005). However, it is noted that these findings are 
only preliminary and the data sample for the current study focuses specifically on a metropolitan city. 
Nevertheless, the results suggest that a considerable proportion of drivers may be at risk of driving 
under the influence of drugs, rather than alcohol, in the early hours of the morning. In regards to the 
characteristics of the drivers most likely to test positive to illicit substances, such individuals were 
significantly more likely to be males, and under 30 years of age. The results are consistent with 
general drug research that has consistently indicated that males are more likely to consume illicit 
substances than females (Begg and Langley, 2004; Neale, 2004), and in particular, engage in poly 
drug use (Milani, Parrott, Turner & Fox, 2004). 
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Two types of drugs were detected: ecstasy (MDMA) and cannabis (delta 9 THC). Firstly, ecstasy 
(MDMA) was the most common illicit substance identified in the current sample. This finding is in 
contrast to similar recent research conducted in Queensland that indicated that cannabis was the 
most commonly combined drug with driving (Davey et al., 2007), although it is noted this difference 
may be heavily dependent upon specific locations. Additionally, the sample size as well as the 
differences identified between the different drug types was relatively small, and thus the findings need 
to be replicated with larger samples sizes.  
 
Self-reported Drug Driving 
Examination of the self-reported data revealed that cannabis, rather than amphetamines, was the 
most frequently consumed illicit substance, and not surprisingly, was also the most frequent drug to 
be used when driving. The findings support previous research that has indicated cannabis to be the 
most prevalent drug associated with driving (Davey et al., 2007; Drummer et al., 2003; Seymour & 
Oliver, 1999; Swann et al., 2004). Importantly, individuals who tested positive to the drug testing 
process also reported the highest rate of drug driving.  Therefore, the findings also provide 
preliminary evidence that positive drug testing outcomes highlight individuals at risk of regularly 
engaging in drug driving activity, and to a lesser extent, provide support for the reliability of the self-
report data.   
 
Limitations  
Some methodological limitations associated with the study should be borne in mind when interpreting 
the findings. The results of the study may not be generalisable, as a sample from only one area of 
Queensland (a metropolitan city) was utilised in the research project. It is possible that drug use (and 
therefore, drug driving) trends may vary by area, due to differences in the supply, demand, cost and 
potency of drugs. Additionally, the Queensland Police Service generally utilise intelligence-led 
apprehension initiatives, and thus they conduct RBTs in high risk areas (e.g., around licensed areas), 
which most likely also positively influenced the number of identified drugged drivers.  Furthermore, 
the drug testing procedures utilised in the current study only categorised participants into positive and 
negative groups, while future advancements in screening technology may provide an indication of the 
level of impairment which is similar to BAC readings.   And, although a wide age range was observed, 
the sample was skewed towards younger age groups (M = 22 years). It would have been ideal to 
have sampled a group of drivers more representative of all Queensland drivers, however due to the 
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voluntary nature of the study, this did not occur. However importantly, the sample of this study may 
prove to be representative of drivers at night on weekends, which is actually a peak drug driving 
period. However, given that data was only collected between the hours of 5pm and 1am, it is possible 
that drug driving rates may increase or decrease further into the early hours of the morning, as well 
as during the day. Furthermore, the possibility of self-report and volunteer bias remains, and although 
the Queensland Police Service were not directly involved in the research project, it is possible that 
operational officers’ presence at the research site deterred some individuals from participating 
(especially those under the influence of drugs), and exact refusal rates were not obtained. Questions 
also remain about the accurateness of saliva testing for illicit drugs, as environmental contamination 
may negatively affect the accuracy of oral testing e.g., presence in a room where cannabis is being 
smoked (e.g., Davey et al., 2007).  
 
Nevertheless, this research provides evidence that drug driving is relatively prevalent on some 
Queensland roads, and given that research has linked illicit substances with crash involvement, drug 
driving presents as a serious road safety threat. Additionally, considering that previous research has 
indicated that perceptions of apprehension uncertainty are a key element in deterring both drink 
drivers (Piquero & Pogarsky, 2002) and drug drivers (Davey et al., 2005b) from engaging in such 
offending behaviours, drug testing through random roadside saliva techniques has the potential to 
become a viable method to increase perceptions of apprehension uncertainty and thus reduce driving 
under the influence of illicit drugs. As a result, it would be beneficial to examine motorists’ current 
perceptions regarding the likelihood of being detected for drug driving, and their corresponding beliefs 
about the effectiveness, and impact, of saliva testing on offending rates. Such information would 
assist in the current implementation of new random road side testing techniques being conducted in 
Queensland, as well as the promotion of the countermeasure and corresponding drug driving 
legislation. It is noteworthy that researchers have suggested that the Australian community is 
currently not adequately aware of the dangers associated with drug driving (Mallick et al., 2007), and 
that further research is required into identifying the most effective mediums to increase motorists’ 
perceptions regarding the deleterious impact illicit substances have on driving performance. In 
summary, further investigation into drug use and drug driving can only assist with the development 
and implementation of effective countermeasures and supportive enforcement practices aimed at 
reducing the burden of drug driving on road safety.    
 
  
 
   
11
 
 
  
 
   
12
 
Acknowledgements: 
This project was funded by an internal Centre for Accident Research and Road Safety – Queensland 
/ Motor Accident Insurance Commission grant, and was granted ethical approval by the Queensland 
University of Technology Human Research Ethics Committee. A major strength of the study, and the 
key to its successful implementation and completion, was the collaborative relationship between the 
researchers and representatives from the Queensland Police Service. Without their support, this 
project would not have been possible.  
  
 
   
13
 
REFERENCES  
Albery, I. P., Strang, J., Gossop, M., & Griffiths, P. (2000). Illicit drugs and driving: prevalence, beliefs 
and accident involvement among a cohort of current out-of-treatment drug users. Drug and 
Alcohol Dependence, 58, 197-204. 
Armstrong, K., Wills, A., & Watson, B. (2005). Psychosocial influences on drug driving in young 
Australian drivers. Paper presented at the 2005 Australasian Road Safety Research, Policing 
and Education Conference, Wellington, New Zealand.  
Begg, D. J., & Langley, J. D. (2004). Identifying predictors of persistent non-alcohol or drug-related 
risky driving behaviours among a cohort of young drivers. Accident Analysis and Prevention, 
36, 1067-1071.  
Buttress, S. C., Tunbridge, R. J., Oliver, J. S., Torrance, H., & Wylie, F. (2004). The incidence of drink 
and drug driving in the UK – A roadside survey in Glasgow; Proceedings of the 17th 
International Conference on Alcohol, Drugs & Traffic Safety, Glasgow, UK. 
Caldicott, D., Pfeiffer, J., Edwards, N., Pearce, A., & Davey, M. (2007). The impact of drugs on road 
crashes, assaults and other trauma – a prospective trauma toxicology study. Australia: 
National Drug Law Enforcement Research Fund.   
Darke, S., Kelly, E., & Ross, J. (2004). Drug driving among injecting drug users in Sydney, Australia: 
Prevalence, risk factors and risk perceptions. Addiction, 99, 175-185. 
Davey, J., Davey, T., & Obst, P. (2005a).  Drug and drink driving by university students: an 
exploration of the influence of attitudes. Traffic Injury Prevention, 6(1), 44-52. 
Davey, J., Davies, A., French, N., Williams, C., & Lang, C. (2005b) Drug driving from a users 
perspective. Drugs: Education, Prevention and Policy, 12(1), 61-70. 
Davey, J., Leal, N., & Freeman, J. (2007). Screening for drugs in oral fluid: Illicit drug use and drug 
driving in a sample of Queensland motorists. Drug and Alcohol Review, 26(3), 301-307. 
Del Rio, M. C., Gomez, J., Sancho, M., & Alvarez, F. J. (2002). Alcohol, illicit drugs and medicinal 
drugs in fatally injured drivers in Spain between 1991 and 2000. Forensic Science 
International, 127, 63-70. 
Dolan, K., Rouen, D., & Kimber, J. (2004). An overview of the use of urine, hair, sweat and saliva to 
detect drug use. Drug and Alcohol Review, 23, 213-217. 
  
 
   
14
 
Drummer, O. H., Gerostamoulos, H., Batziris, J., Chu, M., Caplehorn, J., Robertson, M.D. & Swann, 
P. (2003). The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic 
Science International, 134, 154-162. 
Drummer O. H., Gerostamoulos, H., Chu, M., Swann, P., Boorman, M., & Cairns, I. (2007). Drugs in 
oral fluid in randomly selected drivers. Forensic Science International, 170, 105-110. 
Hawkins, A., Bryant, P., & Zipparo, L. (2004). Drug users’ attitudes to drugs and driving. Paper 
presented at the Road Safety Research, Policing and Education Conference, Perth, Western 
Australia, 14-16, November.   
Jones, C., Donnelly, N., Swift, W., & Weatherburn, D. (2005). Driving under the influence of cannabis: 
The problem and potential countermeasures. Crime and Justice Bulletin, 87, 225-300. 
Kelly, E., Darke, S., & Ross, J. (2004). A review of drug use and drug driving: epidemiology, 
impairment, risk factors and risk perceptions. Drug and Alcohol Review, 23, 319-344. 
Mallick, J., Johnston, J., Goren, N., & Kennedy, V. (2007).  Drugs and Driving in Australia: a Survey 
of Community Attitudes, Experiences and Understanding. Australian Drug Foundation, 
Australia.   
Milani, R. M., Parrott, A. C., Turner, J.  J., & Fox, H. C. (2004). Gender differences in self-reported 
anxiety, depression and somatisation among ecstasy/MDMA poydrug users, alcohol/tobacco 
users, and nondrug users. Addictive Behaviors, 29, 965-971. 
Mura, P., Chatelain, C., Dumestre, V., Gaulier, J., Ghysel, M., Lacroix, C., Kergueris, M., Lhermitte, 
M., Moulsma, M., Pepin, G., Vincent, F., & Kintz, P. (2006).  Use of drugs of abuse in less 
than 30-yearpold drivers killed in a road crash in France: a spectacular increase for cannabis, 
cocaine and amphetamines. Forensic Science International, 160, 168-172. 
Neale, J. (2004). Drug driving in Scotland: prevalence and correlates amongst drug users entering 
treatment. International Journal of Drug Policy, 15, 27-35. 
Piquero, A. R., & Pogarsky, G. (2002). Beyond Stafford and Warr’s reconceptualization of deterrence: 
personal and vicarious experiences, impulsivity, and offending behavior. Journal of Research 
in Crime and Delinquency, 39(2), 153-186. 
Poyser, C., Makkai, T., Norman, L., & Mills, L. (2002). Drug Driving Among Police Detainees in Three 
States of Australia.  National Drug Law Enforcement Fund: Australia.  
 
  
 
   
15
 
Seymour, A., & Oliver, J. S. (1999). Role of drugs and alcohol in impaired drivers and fatally injured 
drivers in the Strathclyde police region of Scotland, 1995-1998. Forensic Science 
International, 103, 89-100. 
Speedy, T., Baldwin, D., Hand, C. & Jehanli, A. (2004). An integrated device for the collection, 
roadside and laboratory-based testing of oral fluid for drugs of abuse. Proceedings of the 17th 
International Conference on Alcohol, Drugs & Traffic Safety, Glasgow, UK. 
Swann, P. D., Boorman, M. C., & Papafotiou, K. (2004). Impairment and driving assessments of 
drivers given amphetamines, cannabis and benzodiazepines and oral fluid testing results. 
Proceedings of the 17th International Conference on Alcohol, Drugs & Traffic Safety, 
Glasgow, UK. 
Terry, P., & Wright, K. A. (2005). Self-reported driving behaviour and attitudes towards driving under 
the influence of cannabis among three different user groups in England. Addictive Behaviors, 
30, 619-626. 
Watson B., Hart, S., Freeman, J., Tay, R., Davey, J., Madden, J., & Goff, A. (2005). Review of 
Random Breath Testing (RBT) in Queensland. Queensland University of Technology. 
Wylie, F. M., Torrance, H., Seymour, A., Buttress, S., & Oliver, J. S. (2005). Drugs in oral fluid Part II: 
Investigation of drugs in drivers. Forensic Science International, 150, 199-204. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
   
16
 
List of Tables 
Table 1. Number and Proportion of Positive Drug Screening by Drug Group 
 
  
Total³ 
N = 1587 
Males 
N = 1004 
Females 
N = 573 
 
Ecstasy (MDMA) 
Cannabis (THC) 
Amphetamines  
Cocaine 
 
 35 (2.2%) 
 20 (1.3%) 
 17 (1.1%) 
 2 (0.1%) 
 
 28 (2.8%) 
 17 (1.7%) 
 14 (1.4%) 
 1 (0.1%) 
 
 7  (1.2%) 
 3  (0.5%) 
 3  (0.5%)  
 1  (0.2%) 
Total Illicit Substances4  74 (4.6%)  60 (6.0%)  14  (2.4%) 
 
Table 2. Drug Driving Behaviour 
Drug Type   Cannabis Amphetamines  Ecstasy Cocaine Heroin 
     n   %      n    %     n   %      n    %     n    % 
Drug Driving   
 
 
Every Day  26 (1.6)  3 (0.2)  1 (0.1)  0 (0.0) 0 (0.0)
More than once a week  20 (1.3)  3 (0.2)  6 (0.4)  0 (0.0) 1 (0.1)
About once a week  19 (1.2)  12 (0.8)  4 (0.3)  0 (0.0) 0 (0.0)
11-20 times  14 (0.9)  12 (0.8)  7 (0.4)  6 (0.4) 0 (0.0)
3-10 times  18 (1.1)  12 (0.8)  20 (1.3)  5 (0.3) 4 (0.3)
Once or twice  76 (4.8)  28 (1.8)  58 (3.7)  22 (1.4) 5 (0.3)
Never 1399 (88.2) 1509 (95.1) 1481 (93.3) 1545 (97.4) 1568(98.8)
 
 
 
 
 
 
 
_______________________________________________________________________ 
3 10 respondents did not provide their gender. 
4 15 respondents screened positive to more than one drug. 
